What role can psychedelics play in the mental health of cancer patients? And how does mental health impact quality of life? Alyson Moadel-Robblee, Director of Psychosocial Oncology Program and Founding Director of Bronx Oncology Living Daily Program, Montefiore Einstein Center for Cancer Care, and Stephen Ross, Director of NYU Addictive Disorders and Experimental Therapeutics Research Laboratory and Co-Director of NYU Psychedelic Research Group, joined The Atlantic’s Olga Khazan to discuss.
source
